Sigachi Industries Limited
25.95
INR
-0.17
(-0.65%)
ISIN
INE0D0K01022
Return %
Stock
S&P 500
1Y
-32.74
14.20
3Y
-36.86
81.12
5Y
- -
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Amit Raj Sinha
- Full Time Employees
- 1,940
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Plot G 57/2, Industrial Park Hyderabad TS India 502319
- IPO Date
- Nov 15, 2021
- Website
- sigachi.com
- Similar Companies
- Business
- Sigachi Industries Limited is a pharmaceutical excipients and food ingredients manufacturer specializing in Microcrystalline Cellulose (MCC) and related products. The company produces pharmaceutical excipients including Microcrystalline Cellulose, Croscarmellose Sodium, Sodium Starch Glycolate, and Pharmaceutical Coatings. It also manufactures food-grade products such as colloidal MCC grades, Cellulose Fibre, Cellulose Powder, and all-in-one premixes for cake, ice cream, chocolate milk, and salad applications. Sigachi serves the pharmaceutical, nutraceutical, and food industries with a product portfolio that includes Chlorinated Paraffin Wax/Oil, Hydrochloric Acid, Chlorinated Synthetic Resins, and Filter Aid Cellulose. The company operates manufacturing facilities in India, with significant production capacities at its Dahej and Jhagadia sites in Gujarat, alongside its Hyderabad unit. Founded in 1989 and headquartered in Hyderabad, India, Sigachi Industries has expanded its market presence globally, exporting to over 40 countries across Asia, Australia, the Americas, Europe, and the Middle East. The company's strategic focus has been on expanding its excipients and active pharmaceutical ingredients (APIs) business, with recent capacity expansions unlocking an additional 8,800 metric tons per annum in excipients. Sigachi is broadening its geographic footprint through new distribution alliances and turnkey operations in Latin America, Southeast Asia, and the Middle East. It also continues to pursue research and development initiatives with the start of new R&D operations as of July 2025. In recent years, Sigachi has emphasized operational efficiencies by implementing digital analytics and energy management programs to reduce costs annually. The company also manages plant operations outsourcing contracts in the Middle East, contributing about 10% of its revenues, with plans for further growth in this area. In mid-2025, Sigachi responded to a fire incident at its Telangana facility while continuing to expand its product range with new pharmaceutical coating offerings expected to drive future growth. The company remains committed to sustainability initiatives aligned with science-based emissions reduction targets and improving its global competitive position through innovation and geographic market diversification. These developments have reinforced Sigachi’s role as a quality-conscious supplier in the pharmaceutical excipient segment and adjacent sectors. Sigachi Industries Limited operates as a standalone company with no reported parent or subsidiary changes recently. Its core industries include pharmaceuticals, food ingredients, and specialty chemicals, catering primarily to pharma, nutraceutical, and food industry customers. The company is listed on Indian stock exchanges under the ticker SIGACHI.NS. This description reflects the latest product portfolio and strategic initiatives incorporating capacity expansions, market diversification, new product launches, R&D commencement, sustainability focus, and operational advancements up to late 2025.